NASDAQ: OMDA
Omada Health Inc Stock Forecast, Predictions & Price Target

Analyst price target for OMDA

Based on 6 analysts offering 12 month price targets for Omada Health Inc

Min Forecast
$20.00+10.01%
Avg Forecast
$24.17+32.93%
Max Forecast
$29.00+59.52%

Should I buy or sell OMDA stock?

Based on 6 analysts offering ratings for Omada Health Inc.

Strong Buy
Strong Buy
5 analysts 83.33%
Buy
1 analysts 16.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although OMDA's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates OMDA as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their OMDA stock forecasts and price targets.

OMDA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-09
lockedlocked$00.00+00.00%2025-07-01
lockedlocked$00.00+00.00%2025-07-01
lockedlocked$00.00+00.00%2025-07-01
lockedlocked$00.00+00.00%2025-07-01
Needham
Top 21%
80
BuyInitiates Coverage On$23.00+26.51%2025-07-01
Canaccord Genuity
Bottom 2%
2
Strong BuyInitiates Coverage On$27.00+48.51%2025-07-01

1 of 1

Forecast return on equity

Is OMDA forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is OMDA forecast to generate an efficient return on assets?

Company
-4.94%
Industry
10.93%
OMDA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OMDA earnings per share forecast

What is OMDA's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.57
Avg 2 year Forecast
-$0.32
Avg 3 year Forecast
-$0.13

OMDA revenue forecast

What is OMDA's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$221.0M
Avg 2 year Forecast
$266.4M
Avg 3 year Forecast
$321.0M

OMDA vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
AMWL$8.26$8.13-1.63%Hold
BTSG$20.10$26.00+29.35%Strong Buy
CCLD$2.37$1.50-36.71%Hold
BFRG$1.45N/AN/A
ACON$7.70N/AN/A

Omada Health Stock Forecast FAQ

Is Omada Health Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: OMDA) stock is to Strong Buy OMDA stock.

Out of 6 analysts, 5 (83.33%) are recommending OMDA as a Strong Buy, 1 (16.67%) are recommending OMDA as a Buy, 0 (0%) are recommending OMDA as a Hold, 0 (0%) are recommending OMDA as a Sell, and 0 (0%) are recommending OMDA as a Strong Sell.

If you're new to stock investing, here's how to buy Omada Health stock.

What is OMDA's earnings growth forecast for 2025-2027?

(NASDAQ: OMDA) Omada Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 18.93%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.94%.

Omada Health's earnings in 2025 is N/A.On average, 2 Wall Street analysts forecast OMDA's earnings for 2025 to be -$31,495,552, with the lowest OMDA earnings forecast at -$31,774,274, and the highest OMDA earnings forecast at -$31,216,830. On average, 2 Wall Street analysts forecast OMDA's earnings for 2026 to be -$17,838,189, with the lowest OMDA earnings forecast at -$18,953,076, and the highest OMDA earnings forecast at -$16,723,302.

In 2027, OMDA is forecast to generate -$6,968,043 in earnings, with the lowest earnings forecast at -$8,361,651 and the highest earnings forecast at -$5,574,434.

What is OMDA's revenue growth forecast for 2025-2027?

(NASDAQ: OMDA) Omada Health's forecast annual revenue growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 8.98%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.88%.

Omada Health's revenue in 2025 is N/A.On average, 2 Wall Street analysts forecast OMDA's revenue for 2025 to be $12,321,059,982, with the lowest OMDA revenue forecast at $12,319,889,350, and the highest OMDA revenue forecast at $12,322,286,357. On average, 2 Wall Street analysts forecast OMDA's revenue for 2026 to be $14,847,839,425, with the lowest OMDA revenue forecast at $14,845,944,117, and the highest OMDA revenue forecast at $14,849,734,733.

In 2027, OMDA is forecast to generate $17,894,825,049 in revenue, with the lowest revenue forecast at $17,893,933,140 and the highest revenue forecast at $17,895,772,703.

What is OMDA's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: OMDA) forecast ROA is -4.94%, which is lower than the forecast US Health Information Services industry average of 10.93%.

What is OMDA's Price Target?

According to 6 Wall Street analysts that have issued a 1 year OMDA price target, the average OMDA price target is $24.17, with the highest OMDA stock price forecast at $29.00 and the lowest OMDA stock price forecast at $20.00.

On average, Wall Street analysts predict that Omada Health's share price could reach $24.17 by Jul 1, 2026. The average Omada Health stock price prediction forecasts a potential upside of 32.93% from the current OMDA share price of $18.18.

What is OMDA's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: OMDA) Omada Health's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that OMDA's EPS will be -$0.57 for 2025, with the lowest EPS forecast at -$0.57, and the highest EPS forecast at -$0.56. On average, analysts forecast that OMDA's EPS will be -$0.32 for 2026, with the lowest EPS forecast at -$0.34, and the highest EPS forecast at -$0.30. In 2027, OMDA's EPS is forecast to hit -$0.13 (min: -$0.15, max: -$0.10).

What is OMDA's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: OMDA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.